Pyrazinamide Tablet
Product Images NDC 60687-789

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pyrazinamide (NDC 60687-789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 mg Pyrazinamide Tablet Blister (500 mg Pyrazinamide Tablet Blister)

500 mg Pyrazinamide Tablet Blister (500 mg Pyrazinamide Tablet Blister)
The provided text seems to be a label for Pyrazinamide tablets, USP with a strength of 500 mg. It includes information such as lot numbers and some dosage details. The label mentions Pyrazinamide tablet information repeatedly along with the dosage strength.*
FDA Label Image

500 mg Pyrazinamide Tablets Carton (500 mg Pyrazinamide Tablets Carton)

500 mg Pyrazinamide Tablets Carton (500 mg Pyrazinamide Tablets Carton)
The text provided is a description of Pyrazinamide Tablets, USP in a pack of 100 tablets. Each tablet contains 500 mg of Pyrazinamide, and the recommended adult dosage is 5-30 mg/kg once daily, not exceeding 2 g. The tablets are for prescription use only and should be stored between 20°C to 25°C. The medication is manufactured by Nowitium Pharma and distributed by American Health Packaging. The package contains NDC 60687-789-01 for reference and tracking.*
FDA Label Image

Ahp78901

FDA Label Image

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.